Mode
Text Size
Log in / Sign up

PCKP reduces early pain and leakage versus UPKP in osteoporotic vertebral fracturesA Smarter Cement Technique Eases Spine Fracture Pain Faster

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider PCKP for early pain and leakage reduction in moderate-to-severe OVCFs, but monitor long-term outcomes.

This randomized controlled trial enrolled 139 patients with single-level osteoporotic vertebral compression fractures, comparing percutaneous curved kyphoplasty (PCKP) to unilateral percutaneous kyphoplasty (UPKP) over at least 24 months of follow-up. The study did not report primary outcomes, phase, setting, or safety details such as adverse events. Secondary outcomes included pain, function, cement distribution, leakage, and re-fracture incidence.

Main results showed PCKP was superior to UPKP in early outcomes: at 2 days, VAS was 1.99 ± 0.77 for PCKP versus 3.47 ± 0.50 for UPKP (p < 0.001), and ODI was 27.07 ± 1.78 versus 35.33 ± 3.12 (p < 0.001). Cement distribution excellence rates were 91.04% with PCKP compared to 76.39% with UPKP, and leakage rates were lower at 10.45% versus 26.39%. In moderate-to-severe cases, PCKP provided more symmetric cement distribution (p = 0.02) and a 21% lower leakage risk. However, re-fracture incidence (PCKP: 11.94% vs. UPKP: 15.28%) and anti-osteoporosis compliance (PCKP: 28.36% vs. UPKP: 33.33%) showed no significant differences.

Safety and tolerability were not reported, and limitations include unspecified funding or conflicts. Practice relevance suggests PCKP may enhance early biomechanical stability in moderate-to-severe fractures through optimized cement dispersion, but long-term efficacy depends on anti-osteoporosis therapy. A stepwise decision model is recommended, with PCKP for Genant 2–3 cases and UPKP for mild ones, combined with a vertebral augmentation–bone metabolism modulation–behavioral intervention strategy. Clinicians should consider these findings as preliminary due to unreported safety data and the need for further validation.

When Bones Become Fragile

Osteoporosis is a condition that weakens bones, making them thin and brittle over time. It affects an estimated 200 million people worldwide, with postmenopausal women at highest risk. When a vertebra (one of the small bones that make up the spine) collapses under pressure, it is called a vertebral compression fracture (VCF).

These fractures cause severe pain, loss of height, and difficulty moving. In older adults, they can trigger a cascade of decline — less activity, more muscle loss, and a higher risk of future fractures and falls.

The Standard Fix — and Its Limits

The most common minimally invasive treatment for these fractures is kyphoplasty — a procedure where a doctor inserts a needle into the damaged vertebra and injects medical-grade bone cement to stabilize it. This can dramatically reduce pain and restore function without open surgery.

The traditional approach uses a straight needle inserted from one side. But here's the twist: in severe fractures, a straight needle often cannot reach the center of the vertebra or distribute cement evenly across both sides — which may leave some instability behind.

The newer approach — called percutaneous curved kyphoplasty (PCKP) — uses a needle that curves inside the vertebra. Think of the difference between trying to water a plant from one edge of a pot versus being able to arc the nozzle to reach the center. The curved needle can distribute bone cement more symmetrically across the collapsed bone.

The standard technique, unilateral percutaneous kyphoplasty (UPKP), uses a single straight needle inserted from one side. For mild fractures, this works well. But for moderate-to-severe fractures — where the bone has collapsed more severely — the curved approach may offer a mechanical advantage.

What the Trial Tested

This prospective randomized controlled trial (RCT) — the gold standard for comparing medical treatments — enrolled 139 patients with single-level osteoporotic vertebral fractures at a single hospital between January 2021 and January 2023. Patients were randomly assigned to either PCKP (67 patients) or UPKP (72 patients) and followed for at least two years. Outcomes measured included pain levels, disability scores, cement distribution quality, cement leakage rates, and re-fracture rates.

In the first days after surgery, patients who received the curved technique reported significantly better pain relief. On a pain scale from 0 to 10, PCKP patients scored around 2 versus 3.5 for UPKP patients just two days after the procedure. Disability scores followed a similar early advantage.

PCKP also produced better cement distribution (91% excellent distribution versus 76% for UPKP) and a lower cement leakage rate (10.4% versus 26.4%). Leakage — where cement escapes into surrounding tissue — is a known complication that can occasionally cause nerve irritation or other problems.

Here's Where It Gets Complicated

The long-term outcomes told a different story.

By three months post-surgery, pain and disability scores had converged — there was no longer a significant difference between the two groups. Re-fracture rates at two years were also similar (12% for PCKP versus 15% for UPKP).

What did predict long-term outcomes was whether patients consistently took their anti-osteoporosis medications. Fewer than one third of patients in both groups maintained full compliance with these medications — and this affected their recovery regardless of which surgical technique they had.

Spine specialists note that the surgical choice is only one part of the puzzle. Procedures like kyphoplasty stabilize the fracture that already happened — but they do not address the underlying bone fragility that caused it. Without treating osteoporosis aggressively with medication, diet, and activity, the next fracture may not be far away.

This study reinforces a stepwise approach: use the curved technique for more severe fractures to get better early results, but pair the surgery with serious attention to long-term bone health management.

If you or an older family member is facing a spinal compression fracture, it is worth asking the treating surgeon what level of fracture severity is involved and whether the curved-needle approach is available and appropriate. Either way, make sure the conversation includes a plan for osteoporosis treatment after the procedure — because that matters just as much for preventing the next fracture. This research is based on a clinical trial, so both techniques discussed are real options already in use at many centers.

Where the Study Has Limits

This trial enrolled patients at a single hospital in China, which may limit how widely the results apply. The study also could not blind patients or surgeons to which technique was used, which is inherent to surgical trials. The relatively low anti-osteoporosis medication compliance in both groups limits what the study could conclude about the combined impact of surgery plus optimal medical therapy.

Future research needs to test what happens when the curved surgical technique is combined with strict, well-monitored anti-osteoporosis therapy — a combination this study could not fully evaluate due to low medication compliance. Multicenter trials with diverse populations and longer follow-up would also help clarify which patients benefit most from each approach. Ultimately, the goal is a personalized decision framework where fracture severity, bone density, and medical history all guide which procedure a patient receives.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BackgroundPercutaneous curved kyphoplasty (PCKP) demonstrates early advantages in treating osteoporotic vertebral compression fractures (OVCFs), but its long-term efficacy and patient-selection criteria remain controversial.ObjectiveThe aim of this study is to prospectively compare the mid-to-long-term outcomes of PCKP versus unilateral percutaneous kyphoplasty (UPKP) for single-level OVCFs and establish a hierarchical decision model based on vertebral compression severity.MethodsA total of 139 patients with single-level OVCFs (January 2021–January 2023) were randomized to PCKP (n = 67) or UPKP (n = 72), with ≥24-month follow-up. Outcomes included the visual analog score (VAS), Oswestry dysfunction index (ODI), cement distribution (type I–V classification), leakage rate, and re-fracture incidence. Anti-osteoporosis compliance was analyzed for its impact on efficacy.ResultsBoth groups showed significant postoperative improvement in VAS and ODI (p < 0.05). PCKP achieved superior early pain relief (VAS: 1.99 ± 0.77 vs. 3.47 ± 0.50; ODI: 27.07 ± 1.78 vs. 35.33 ± 3.12 at 2 days, p < 0.001), a higher cement distribution excellence rate (91.04% vs. 76.39%), and a lower leakage rate (10.45% vs. 26.39%). However, outcomes converged from 3 months onward (p > 0.05), with no significant differences in re-fracture (11.94% vs. 15.28%) or anti-osteoporosis compliance (28.36% vs. 33.33%). Subgroup analysis revealed that PCKP provided more symmetric cement distribution (p = 0.02) and a 21% lower leakage risk in moderate-to-severe OVCFs (Genant 2–3).ConclusionPCKP enhances early biomechanical stability in moderate-to-severe OVCFs through optimized cement dispersion, while long-term efficacy relies on standardized anti-osteoporosis therapy. A stepwise decision model (“PCKP for Genant 2–3, UPKP for mild cases”), combined with a “vertebral augmentation–bone metabolism modulation–behavioral intervention” strategy, is recommended.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.